Co-Authors
This is a "connection" page, showing publications co-authored by Yatin Mehta and Rahul Pandit.
Connection Strength
0.115
-
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial. Lancet Respir Med. 2021 05; 9(5):511-521.
Score: 0.058
-
Current Approaches to COVID-19: Therapy and Prevention. Indian J Crit Care Med. 2020 Sep; 24(9):838-846.
Score: 0.056